nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—Breast pain female—Octreotide—thymus cancer	0.0438	0.0521	CcSEcCtD
Topiramate—Abdominal tenderness—Octreotide—thymus cancer	0.0252	0.0299	CcSEcCtD
Topiramate—Diabetic—Octreotide—thymus cancer	0.019	0.0226	CcSEcCtD
Topiramate—Pruritus generalised—Octreotide—thymus cancer	0.019	0.0226	CcSEcCtD
Topiramate—Clotting—Octreotide—thymus cancer	0.0178	0.0212	CcSEcCtD
Topiramate—Prostatic disorder—Octreotide—thymus cancer	0.015	0.0178	CcSEcCtD
Topiramate—Intraocular pressure increased—Octreotide—thymus cancer	0.0145	0.0172	CcSEcCtD
Topiramate—Ulcerative stomatitis—Octreotide—thymus cancer	0.0138	0.0164	CcSEcCtD
Topiramate—Loss of libido—Octreotide—thymus cancer	0.0138	0.0164	CcSEcCtD
Topiramate—Pancreatitis acute—Octreotide—thymus cancer	0.0138	0.0164	CcSEcCtD
Topiramate—Sinus bradycardia—Octreotide—thymus cancer	0.013	0.0154	CcSEcCtD
Topiramate—Renal pain—Octreotide—thymus cancer	0.0121	0.0144	CcSEcCtD
Topiramate—GRIK3—pituitary gland—thymus cancer	0.0114	0.0877	CbGeAlD
Topiramate—GRIK5—pituitary gland—thymus cancer	0.0114	0.0877	CbGeAlD
Topiramate—Haemorrhoids—Octreotide—thymus cancer	0.0108	0.0129	CcSEcCtD
Topiramate—Haematoma—Octreotide—thymus cancer	0.0101	0.012	CcSEcCtD
Topiramate—GRIK5—thyroid gland—thymus cancer	0.00984	0.0756	CbGeAlD
Topiramate—Nail disorder—Octreotide—thymus cancer	0.0098	0.0117	CcSEcCtD
Topiramate—Redness—Octreotide—thymus cancer	0.00941	0.0112	CcSEcCtD
Topiramate—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.00932	0.0111	CcSEcCtD
Topiramate—Paranoia—Octreotide—thymus cancer	0.00932	0.0111	CcSEcCtD
Topiramate—Menstrual disorder—Octreotide—thymus cancer	0.00932	0.0111	CcSEcCtD
Topiramate—Burning sensation—Octreotide—thymus cancer	0.00915	0.0109	CcSEcCtD
Topiramate—Metrorrhagia—Octreotide—thymus cancer	0.0089	0.0106	CcSEcCtD
Topiramate—Influenza-like symptoms—Octreotide—thymus cancer	0.0089	0.0106	CcSEcCtD
Topiramate—Coagulopathy—Octreotide—thymus cancer	0.00816	0.00971	CcSEcCtD
Topiramate—Otitis media—Octreotide—thymus cancer	0.00816	0.00971	CcSEcCtD
Topiramate—Nephrolithiasis—Octreotide—thymus cancer	0.00791	0.0094	CcSEcCtD
Topiramate—Endocrine disorder—Octreotide—thymus cancer	0.00767	0.00912	CcSEcCtD
Topiramate—Acne—Octreotide—thymus cancer	0.00755	0.00898	CcSEcCtD
Topiramate—Sensory loss—Octreotide—thymus cancer	0.00734	0.00872	CcSEcCtD
Topiramate—Breast pain—Octreotide—thymus cancer	0.00728	0.00866	CcSEcCtD
Topiramate—Amenorrhoea—Octreotide—thymus cancer	0.00723	0.0086	CcSEcCtD
Topiramate—Viral infection—Octreotide—thymus cancer	0.00704	0.00837	CcSEcCtD
Topiramate—Arthropathy—Octreotide—thymus cancer	0.00699	0.00831	CcSEcCtD
Topiramate—Drug interaction—Octreotide—thymus cancer	0.00685	0.00815	CcSEcCtD
Topiramate—Hearing impaired—Octreotide—thymus cancer	0.00668	0.00794	CcSEcCtD
Topiramate—Muscle twitching—Octreotide—thymus cancer	0.00647	0.0077	CcSEcCtD
Topiramate—Vaginal inflammation—Octreotide—thymus cancer	0.00636	0.00756	CcSEcCtD
Topiramate—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00636	0.00756	CcSEcCtD
Topiramate—Cystitis noninfective—Octreotide—thymus cancer	0.00621	0.00738	CcSEcCtD
Topiramate—Influenza like illness—Octreotide—thymus cancer	0.00617	0.00734	CcSEcCtD
Topiramate—Cystitis—Octreotide—thymus cancer	0.00614	0.0073	CcSEcCtD
Topiramate—GRIK5—lymph node—thymus cancer	0.00611	0.0469	CbGeAlD
Topiramate—GRIK3—lymph node—thymus cancer	0.00611	0.0469	CbGeAlD
Topiramate—Candida infection—Octreotide—thymus cancer	0.00607	0.00722	CcSEcCtD
Topiramate—Vaginal infection—Octreotide—thymus cancer	0.006	0.00714	CcSEcCtD
Topiramate—Neuropathy—Octreotide—thymus cancer	0.00597	0.0071	CcSEcCtD
Topiramate—Cramps of lower extremities—Octreotide—thymus cancer	0.00584	0.00694	CcSEcCtD
Topiramate—Mouth ulceration—Octreotide—thymus cancer	0.00575	0.00683	CcSEcCtD
Topiramate—Bladder pain—Octreotide—thymus cancer	0.00575	0.00683	CcSEcCtD
Topiramate—Urine output increased—Octreotide—thymus cancer	0.00575	0.00683	CcSEcCtD
Topiramate—Hyperkinesia—Octreotide—thymus cancer	0.00554	0.00659	CcSEcCtD
Topiramate—Phlebitis—Octreotide—thymus cancer	0.00536	0.00637	CcSEcCtD
Topiramate—Sleep disorder—Octreotide—thymus cancer	0.00533	0.00634	CcSEcCtD
Topiramate—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.0053	0.00631	CcSEcCtD
Topiramate—Diabetes mellitus—Octreotide—thymus cancer	0.0053	0.00631	CcSEcCtD
Topiramate—Polyuria—Octreotide—thymus cancer	0.00525	0.00625	CcSEcCtD
Topiramate—Gastroenteritis—Octreotide—thymus cancer	0.00521	0.00619	CcSEcCtD
Topiramate—Deafness—Octreotide—thymus cancer	0.00516	0.00613	CcSEcCtD
Topiramate—Nasal congestion—Octreotide—thymus cancer	0.00506	0.00602	CcSEcCtD
Topiramate—Hot flush—Octreotide—thymus cancer	0.00493	0.00586	CcSEcCtD
Topiramate—Amnesia—Octreotide—thymus cancer	0.00491	0.00584	CcSEcCtD
Topiramate—Menopausal symptoms—Octreotide—thymus cancer	0.00489	0.00581	CcSEcCtD
Topiramate—Visual disturbance—Octreotide—thymus cancer	0.00487	0.00579	CcSEcCtD
Topiramate—Hypoglycaemia—Octreotide—thymus cancer	0.00473	0.00562	CcSEcCtD
Topiramate—Pain in extremity—Octreotide—thymus cancer	0.00461	0.00549	CcSEcCtD
Topiramate—Osteoarthritis—Octreotide—thymus cancer	0.00461	0.00549	CcSEcCtD
Topiramate—Psychotic disorder—Octreotide—thymus cancer	0.00451	0.00536	CcSEcCtD
Topiramate—Irritability—Octreotide—thymus cancer	0.0044	0.00524	CcSEcCtD
Topiramate—CA5B—hematopoietic system—thymus cancer	0.00437	0.0335	CbGeAlD
Topiramate—Dehydration—Octreotide—thymus cancer	0.00429	0.0051	CcSEcCtD
Topiramate—GRIA1—lung—thymus cancer	0.00422	0.0324	CbGeAlD
Topiramate—Abdominal pain upper—Octreotide—thymus cancer	0.00421	0.00501	CcSEcCtD
Topiramate—Nasopharyngitis—Octreotide—thymus cancer	0.00413	0.00491	CcSEcCtD
Topiramate—Gastritis—Octreotide—thymus cancer	0.00408	0.00486	CcSEcCtD
Topiramate—Muscular weakness—Octreotide—thymus cancer	0.00407	0.00484	CcSEcCtD
Topiramate—CA4—neck—thymus cancer	0.00405	0.0311	CbGeAlD
Topiramate—Abdominal distension—Octreotide—thymus cancer	0.00401	0.00477	CcSEcCtD
Topiramate—Asthma—Octreotide—thymus cancer	0.00399	0.00474	CcSEcCtD
Topiramate—Pancreatitis—Octreotide—thymus cancer	0.00391	0.00465	CcSEcCtD
Topiramate—Sweating increased—Octreotide—thymus cancer	0.00388	0.00462	CcSEcCtD
Topiramate—CA1—hematopoietic system—thymus cancer	0.00386	0.0296	CbGeAlD
Topiramate—Bronchitis—Octreotide—thymus cancer	0.00383	0.00456	CcSEcCtD
Topiramate—Abdominal discomfort—Octreotide—thymus cancer	0.00382	0.00455	CcSEcCtD
Topiramate—Dysuria—Octreotide—thymus cancer	0.00373	0.00443	CcSEcCtD
Topiramate—Upper respiratory tract infection—Octreotide—thymus cancer	0.00371	0.00441	CcSEcCtD
Topiramate—Pollakiuria—Octreotide—thymus cancer	0.00368	0.00438	CcSEcCtD
Topiramate—Weight increased—Octreotide—thymus cancer	0.00363	0.00432	CcSEcCtD
Topiramate—Weight decreased—Octreotide—thymus cancer	0.00361	0.00429	CcSEcCtD
Topiramate—Hyperglycaemia—Octreotide—thymus cancer	0.0036	0.00428	CcSEcCtD
Topiramate—Pneumonia—Octreotide—thymus cancer	0.00358	0.00425	CcSEcCtD
Topiramate—GRIK4—Neuronal System—KCNA4—thymus cancer	0.00357	0.124	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—KCNA4—thymus cancer	0.00357	0.124	CbGpPWpGaD
Topiramate—Depression—Octreotide—thymus cancer	0.00355	0.00422	CcSEcCtD
Topiramate—Neuropathy peripheral—Octreotide—thymus cancer	0.00349	0.00414	CcSEcCtD
Topiramate—Conjunctivitis—Octreotide—thymus cancer	0.00346	0.00411	CcSEcCtD
Topiramate—Urinary tract infection—Octreotide—thymus cancer	0.00346	0.00411	CcSEcCtD
Topiramate—Haematuria—Octreotide—thymus cancer	0.00339	0.00403	CcSEcCtD
Topiramate—CA2—neck—thymus cancer	0.00336	0.0258	CbGeAlD
Topiramate—Epistaxis—Octreotide—thymus cancer	0.00335	0.00399	CcSEcCtD
Topiramate—Sinusitis—Octreotide—thymus cancer	0.00334	0.00397	CcSEcCtD
Topiramate—GRIK1—Neuronal System—KCNA4—thymus cancer	0.00332	0.115	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—KCNA4—thymus cancer	0.00332	0.115	CbGpPWpGaD
Topiramate—CA5B—cardiac atrium—thymus cancer	0.00332	0.0255	CbGeAlD
Topiramate—Bradycardia—Octreotide—thymus cancer	0.00325	0.00386	CcSEcCtD
Topiramate—SCN5A—cardiac atrium—thymus cancer	0.00321	0.0247	CbGeAlD
Topiramate—Rhinitis—Octreotide—thymus cancer	0.0032	0.0038	CcSEcCtD
Topiramate—Hepatitis—Octreotide—thymus cancer	0.00319	0.0038	CcSEcCtD
Topiramate—Hypoaesthesia—Octreotide—thymus cancer	0.00318	0.00378	CcSEcCtD
Topiramate—Pharyngitis—Octreotide—thymus cancer	0.00317	0.00377	CcSEcCtD
Topiramate—Oedema peripheral—Octreotide—thymus cancer	0.00314	0.00374	CcSEcCtD
Topiramate—Visual impairment—Octreotide—thymus cancer	0.00308	0.00366	CcSEcCtD
Topiramate—SCN1A—lung—thymus cancer	0.00306	0.0235	CbGeAlD
Topiramate—GABRG2—pituitary gland—thymus cancer	0.00304	0.0234	CbGeAlD
Topiramate—Tinnitus—Octreotide—thymus cancer	0.00298	0.00354	CcSEcCtD
Topiramate—Cardiac disorder—Octreotide—thymus cancer	0.00296	0.00352	CcSEcCtD
Topiramate—Flushing—Octreotide—thymus cancer	0.00296	0.00352	CcSEcCtD
Topiramate—Immune system disorder—Octreotide—thymus cancer	0.00288	0.00343	CcSEcCtD
Topiramate—CA12—lung—thymus cancer	0.00283	0.0217	CbGeAlD
Topiramate—Alopecia—Octreotide—thymus cancer	0.00282	0.00335	CcSEcCtD
Topiramate—GRIA4—Neuronal System—KCNA4—thymus cancer	0.00282	0.0978	CbGpPWpGaD
Topiramate—Mental disorder—Octreotide—thymus cancer	0.0028	0.00332	CcSEcCtD
Topiramate—CA5B—thyroid gland—thymus cancer	0.00279	0.0214	CbGeAlD
Topiramate—Malnutrition—Octreotide—thymus cancer	0.00278	0.0033	CcSEcCtD
Topiramate—Erythema—Octreotide—thymus cancer	0.00278	0.0033	CcSEcCtD
Topiramate—Flatulence—Octreotide—thymus cancer	0.00274	0.00326	CcSEcCtD
Topiramate—CYP2C19—hematopoietic system—thymus cancer	0.00273	0.0209	CbGeAlD
Topiramate—Tension—Octreotide—thymus cancer	0.00273	0.00324	CcSEcCtD
Topiramate—CA1—lymphoid tissue—thymus cancer	0.00271	0.0208	CbGeAlD
Topiramate—Nervousness—Octreotide—thymus cancer	0.0027	0.00321	CcSEcCtD
Topiramate—Back pain—Octreotide—thymus cancer	0.00269	0.0032	CcSEcCtD
Topiramate—Muscle spasms—Octreotide—thymus cancer	0.00267	0.00318	CcSEcCtD
Topiramate—Vision blurred—Octreotide—thymus cancer	0.00262	0.00311	CcSEcCtD
Topiramate—Tremor—Octreotide—thymus cancer	0.0026	0.0031	CcSEcCtD
Topiramate—Ill-defined disorder—Octreotide—thymus cancer	0.00258	0.00307	CcSEcCtD
Topiramate—Anaemia—Octreotide—thymus cancer	0.00257	0.00305	CcSEcCtD
Topiramate—Agitation—Octreotide—thymus cancer	0.00255	0.00304	CcSEcCtD
Topiramate—CA5B—lung—thymus cancer	0.00254	0.0195	CbGeAlD
Topiramate—Malaise—Octreotide—thymus cancer	0.00251	0.00298	CcSEcCtD
Topiramate—CA2—hematopoietic system—thymus cancer	0.0025	0.0192	CbGeAlD
Topiramate—Vertigo—Octreotide—thymus cancer	0.0025	0.00297	CcSEcCtD
Topiramate—Syncope—Octreotide—thymus cancer	0.00249	0.00296	CcSEcCtD
Topiramate—CA1—bone marrow—thymus cancer	0.00247	0.019	CbGeAlD
Topiramate—Palpitations—Octreotide—thymus cancer	0.00246	0.00292	CcSEcCtD
Topiramate—Loss of consciousness—Octreotide—thymus cancer	0.00244	0.0029	CcSEcCtD
Topiramate—Cough—Octreotide—thymus cancer	0.00242	0.00288	CcSEcCtD
Topiramate—Convulsion—Octreotide—thymus cancer	0.00241	0.00286	CcSEcCtD
Topiramate—Hypertension—Octreotide—thymus cancer	0.0024	0.00285	CcSEcCtD
Topiramate—GABRB2—lung—thymus cancer	0.00238	0.0183	CbGeAlD
Topiramate—Arthralgia—Octreotide—thymus cancer	0.00237	0.00281	CcSEcCtD
Topiramate—Chest pain—Octreotide—thymus cancer	0.00237	0.00281	CcSEcCtD
Topiramate—Myalgia—Octreotide—thymus cancer	0.00237	0.00281	CcSEcCtD
Topiramate—Anxiety—Octreotide—thymus cancer	0.00236	0.0028	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00235	0.00279	CcSEcCtD
Topiramate—Discomfort—Octreotide—thymus cancer	0.00234	0.00278	CcSEcCtD
Topiramate—Dry mouth—Octreotide—thymus cancer	0.00231	0.00275	CcSEcCtD
Topiramate—CA4—cardiac atrium—thymus cancer	0.00229	0.0176	CbGeAlD
Topiramate—CA2—epithelium—thymus cancer	0.00228	0.0175	CbGeAlD
Topiramate—Oedema—Octreotide—thymus cancer	0.00227	0.0027	CcSEcCtD
Topiramate—Infection—Octreotide—thymus cancer	0.00225	0.00268	CcSEcCtD
Topiramate—CA1—lung—thymus cancer	0.00224	0.0172	CbGeAlD
Topiramate—CA4—pituitary gland—thymus cancer	0.00224	0.0172	CbGeAlD
Topiramate—Shock—Octreotide—thymus cancer	0.00223	0.00265	CcSEcCtD
Topiramate—Nervous system disorder—Octreotide—thymus cancer	0.00222	0.00264	CcSEcCtD
Topiramate—Thrombocytopenia—Octreotide—thymus cancer	0.00222	0.00264	CcSEcCtD
Topiramate—Tachycardia—Octreotide—thymus cancer	0.00221	0.00263	CcSEcCtD
Topiramate—Skin disorder—Octreotide—thymus cancer	0.0022	0.00262	CcSEcCtD
Topiramate—Hyperhidrosis—Octreotide—thymus cancer	0.00219	0.00261	CcSEcCtD
Topiramate—Anorexia—Octreotide—thymus cancer	0.00216	0.00257	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00207	0.00246	CcSEcCtD
Topiramate—Insomnia—Octreotide—thymus cancer	0.00205	0.00244	CcSEcCtD
Topiramate—GRIA3—Neuronal System—KCNA4—thymus cancer	0.00205	0.0711	CbGpPWpGaD
Topiramate—Paraesthesia—Octreotide—thymus cancer	0.00204	0.00242	CcSEcCtD
Topiramate—Dyspnoea—Octreotide—thymus cancer	0.00202	0.0024	CcSEcCtD
Topiramate—Somnolence—Octreotide—thymus cancer	0.00202	0.0024	CcSEcCtD
Topiramate—Dyspepsia—Octreotide—thymus cancer	0.002	0.00237	CcSEcCtD
Topiramate—Decreased appetite—Octreotide—thymus cancer	0.00197	0.00234	CcSEcCtD
Topiramate—Gastrointestinal disorder—Octreotide—thymus cancer	0.00196	0.00233	CcSEcCtD
Topiramate—Fatigue—Octreotide—thymus cancer	0.00195	0.00232	CcSEcCtD
Topiramate—Pain—Octreotide—thymus cancer	0.00194	0.00231	CcSEcCtD
Topiramate—Constipation—Octreotide—thymus cancer	0.00194	0.00231	CcSEcCtD
Topiramate—CA4—bone marrow—thymus cancer	0.00193	0.0148	CbGeAlD
Topiramate—CA4—thyroid gland—thymus cancer	0.00193	0.0148	CbGeAlD
Topiramate—CA2—cardiac atrium—thymus cancer	0.0019	0.0146	CbGeAlD
Topiramate—Feeling abnormal—Octreotide—thymus cancer	0.00187	0.00222	CcSEcCtD
Topiramate—Gastrointestinal pain—Octreotide—thymus cancer	0.00185	0.0022	CcSEcCtD
Topiramate—CA2—pituitary gland—thymus cancer	0.00185	0.0142	CbGeAlD
Topiramate—Urticaria—Octreotide—thymus cancer	0.0018	0.00214	CcSEcCtD
Topiramate—Body temperature increased—Octreotide—thymus cancer	0.00179	0.00213	CcSEcCtD
Topiramate—Abdominal pain—Octreotide—thymus cancer	0.00179	0.00213	CcSEcCtD
Topiramate—CA2—lymphoid tissue—thymus cancer	0.00176	0.0135	CbGeAlD
Topiramate—CA4—lung—thymus cancer	0.00175	0.0134	CbGeAlD
Topiramate—CA5B—lymph node—thymus cancer	0.00173	0.0133	CbGeAlD
Topiramate—Hypersensitivity—Octreotide—thymus cancer	0.00167	0.00199	CcSEcCtD
Topiramate—Asthenia—Octreotide—thymus cancer	0.00163	0.00193	CcSEcCtD
Topiramate—CYP3A4—hematopoietic system—thymus cancer	0.00161	0.0124	CbGeAlD
Topiramate—Pruritus—Octreotide—thymus cancer	0.0016	0.00191	CcSEcCtD
Topiramate—CA2—bone marrow—thymus cancer	0.0016	0.0123	CbGeAlD
Topiramate—CA2—thyroid gland—thymus cancer	0.0016	0.0123	CbGeAlD
Topiramate—Diarrhoea—Octreotide—thymus cancer	0.00155	0.00184	CcSEcCtD
Topiramate—CA1—lymph node—thymus cancer	0.00153	0.0118	CbGeAlD
Topiramate—Dizziness—Octreotide—thymus cancer	0.0015	0.00178	CcSEcCtD
Topiramate—CA2—lung—thymus cancer	0.00145	0.0111	CbGeAlD
Topiramate—Vomiting—Octreotide—thymus cancer	0.00144	0.00171	CcSEcCtD
Topiramate—Rash—Octreotide—thymus cancer	0.00143	0.0017	CcSEcCtD
Topiramate—Dermatitis—Octreotide—thymus cancer	0.00143	0.0017	CcSEcCtD
Topiramate—Headache—Octreotide—thymus cancer	0.00142	0.00169	CcSEcCtD
Topiramate—Nausea—Octreotide—thymus cancer	0.00135	0.0016	CcSEcCtD
Topiramate—GRIA1—Neuronal System—KCNA4—thymus cancer	0.00123	0.0426	CbGpPWpGaD
Topiramate—CA4—lymph node—thymus cancer	0.0012	0.00919	CbGeAlD
Topiramate—GRIK2—Neuronal System—KCNA4—thymus cancer	0.00112	0.0389	CbGpPWpGaD
Topiramate—CA2—lymph node—thymus cancer	0.000993	0.00762	CbGeAlD
Topiramate—SCN1A—Axon guidance—DPYSL5—thymus cancer	0.00088	0.0305	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—KCNA4—thymus cancer	0.000858	0.0298	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—KCNA4—thymus cancer	0.000645	0.0224	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—DPYSL5—thymus cancer	0.000628	0.0218	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—DPYSL5—thymus cancer	0.000619	0.0215	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—KCNA4—thymus cancer	0.00059	0.0205	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—KCNA4—thymus cancer	0.000515	0.0179	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—DPYSL5—thymus cancer	0.000441	0.0153	CbGpPWpGaD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—KIT—thymus cancer	0.000401	0.0139	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—KIT—thymus cancer	0.000382	0.0132	CbGpPWpGaD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—TP53—thymus cancer	0.000371	0.0129	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CDKN2A—thymus cancer	0.00031	0.0107	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CD4—thymus cancer	0.000292	0.0101	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—AKT1—thymus cancer	0.00018	0.00625	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000155	0.00539	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDKN2A—thymus cancer	0.000109	0.00378	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—AKT1—thymus cancer	0.000108	0.00374	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—AKT1—thymus cancer	7.55e-05	0.00262	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—thymus cancer	6.07e-05	0.0021	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—thymus cancer	3.65e-05	0.00127	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—thymus cancer	2.57e-05	0.00089	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—thymus cancer	2.21e-05	0.000768	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—thymus cancer	2.21e-05	0.000768	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—thymus cancer	2.07e-05	0.000717	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—thymus cancer	2.07e-05	0.000717	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—thymus cancer	1.92e-05	0.000664	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—thymus cancer	1.53e-05	0.00053	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—thymus cancer	1.46e-05	0.000508	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—thymus cancer	1.4e-05	0.000487	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—thymus cancer	1.23e-05	0.000428	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—thymus cancer	3.45e-06	0.00012	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—thymus cancer	2.08e-06	7.21e-05	CbGpPWpGaD
